tirzepatide march 2025 and Semaglutide key differences, weight loss results (2026) Readout Newsletter: Makary hearing, Hims,

Retatrutide is an investigational triple incretin agonist (GLP-1, GIP, glucagon) not yet licensed by the MHRA or EMA in the UK

This article dives into the latest evidence, unpacking what science actually says and why the answer may be more complex than it seems

Why Does TRT Sometimes Cause Polycythemia

These results confirmed the efficacy and safety of CagriSema in the more metabolically complex population of patients with both obesity and type 2 diabetes

Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment

To the best of our knowledge, this is the first study to explore the relationship between gut fungi and HCC